Blog Featured For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Bridget Baldwin March 11, 2026
Featured Therapeutics Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic Bridget Baldwin February 17, 2026
Featured Therapeutics Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats Bridget Baldwin December 8, 2025
Therapeutics CRISPR Treatments for AI-Designed Synthetic Viruses: Rapid Programmable Countermeasures for Emerging and Engineered Viruses Bridget Baldwin December 5, 2025
Featured Therapeutics Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever Bridget Baldwin November 17, 2025
Blog Featured Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation Bridget Baldwin October 23, 2025
Featured Therapeutics Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™ Bridget Baldwin October 21, 2025
Featured Therapeutics Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ Bridget Baldwin October 7, 2025
Diagnostics Featured Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award Bridget Baldwin October 6, 2025
